Genetic and pharmacological interrogation of cancer vulnerability using a multiplexed cell line screening platform
Xia et al. report the development and optimization of a high-throughput screening platform to systematically determine cancer cell sensitivity to pharmacological and genetic perturbations, BMS-PRISM, based on PRISM and high-throughput CRISPR/Cas9 loss-of-function screen technologies using cell line...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/4d8d29c70bdc4a77a7632fc27bcf2dfd |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|